883 related articles for article (PubMed ID: 33081686)
1. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
2. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
Sangeetha S; Murali M
Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.
Golbaghi G; Pitard I; Lucas M; Haghdoost MM; de Los Santos YL; Doucet N; Patten SA; Sanderson JT; Castonguay A
Eur J Med Chem; 2020 Feb; 188():112030. PubMed ID: 31945643
[TBL] [Abstract][Full Text] [Related]
5. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological properties of tetranuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand.
Sun B; Sundaraneedi MK; Southam HM; Poole RK; Musgrave IF; Keene FR; Collins JG
Dalton Trans; 2019 Oct; 48(38):14505-14515. PubMed ID: 31531475
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
[TBL] [Abstract][Full Text] [Related]
8. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
9. Spectral characteristics, DNA-binding and cytotoxicity of two functional Ru(II) mixed-ligand complexes.
Tan L; Shen J; Liu J; Zeng L; Jin L; Weng C
Dalton Trans; 2012 Apr; 41(15):4575-87. PubMed ID: 22358386
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F
Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574
[TBL] [Abstract][Full Text] [Related]
11. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
[TBL] [Abstract][Full Text] [Related]
12. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
13. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
[TBL] [Abstract][Full Text] [Related]
14. Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand.
Côrte-Real L; Karas B; Gírio P; Moreno A; Avecilla F; Marques F; Buckley BT; Cooper KR; Doherty C; Falson P; Garcia MH; Valente A
Eur J Med Chem; 2019 Feb; 163():853-863. PubMed ID: 30579125
[TBL] [Abstract][Full Text] [Related]
15. Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.
Franco Machado J; Machuqueiro M; Marques F; Robalo MP; Piedade MFM; Garcia MH; Correia JDG; Morais TS
Dalton Trans; 2020 May; 49(18):5974-5987. PubMed ID: 32314752
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, molecular structure, biological properties and molecular docking studies on Mn(II), Co(II) and Zn(II) complexes containing bipyridine-azide ligands.
Thamilarasan V; Jayamani A; Sengottuvelan N
Eur J Med Chem; 2015 Jan; 89():266-78. PubMed ID: 25462243
[TBL] [Abstract][Full Text] [Related]
18. The trans-[Ru(PPh
Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
[TBL] [Abstract][Full Text] [Related]
19. Biological properties of novel ruthenium- and osmium-nitrosyl complexes with azole heterocycles.
Novak MS; Büchel GE; Keppler BK; Jakupec MA
J Biol Inorg Chem; 2016 Jun; 21(3):347-56. PubMed ID: 26961253
[TBL] [Abstract][Full Text] [Related]
20. Copper complex with sulfamethazine and 2,2'-bipyridine supported on mesoporous silica microspheres improves its antitumor action toward human osteosarcoma cells: cyto- and genotoxic effects.
Cadavid-Vargas JF; Arnal PM; Mojica Sepúlveda RD; Rizzo A; Soria DB; Di Virgilio AL
Biometals; 2019 Feb; 32(1):21-32. PubMed ID: 30334122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
